Researchers from Sweden and the U.S. recently published data in JAMA Network Open on adverse and positive health outcomes of five psychedelics consumed by U.S. adults from the 2025 National Survey Investigating Hallucinogenic Trends.
From The Microdose.
Read more
Psychedelic experiences are often described as having religious, spiritual, or other significance.
However, renewed interest in psychedelics is occurring in pluralistic societies where more people are becoming spiritual but not religious.
Read more
Psychedelics have brought mysticism into modern medicine.
What happens when transcendent experiences collide with a culture that lacks language for understanding them? Researchers are listening.
Read more
In an essay published in International Journal of Drug Policy, Dutch psychology researcher Julian Heller and philosopher Yogi Hendlin argue that such attempts to take the trip out of psychedelics are a mistake.
The duo explain that psychedelics’ therapeutic potential is not merely neurochemical, but “highly dependent on subjective experience and environmental context.”
Read more
A recent report from the Substance Abuse and Mental Health Services Administration (SAMHSA) encourages U.S. states to begin preparing for possible approval of psychedelic therapies by the Food and Drug Administration.
The transition from research to clinics is moving faster than those in the field anticipated even five years ago, the report notes, and being proactive is important.
“The question is not whether individuals in a particular state will use psychedelics, but whether they will do so in regulated, safe contexts or in underground networks,” the report reads.
Read more
Professor David Nutt joins WIRED to answer the internet’s burning questions about psychedelic therapy.
Do magic mushrooms combat depression? How does ketamine therapy work? What happened during Bryan Johnson’s 5-MeO-DMT livestream? Answers to these questions and many more await on Psychedelic Therapy Support.
Read more
Scientist Bruce Damer contends psychedelics hold potential for more than addressing the mental health crisis.
He is driven by the belief that psychedelic drugs can crack open the minds of scientists and other problem-solvers.
In 2023, he founded the nonprofit organization the Center for MINDS (Multidisciplinary Investigation into Novel Discoveries and Solutions). Its philosophy: “Psychedelics and other consciousness practices may be our greatest underutilized tool for sparking paradigm-shifting breakthroughs.”
Read more
Quisque iaculis facilisis lacinia. Mauris euismod pellentesque tellus sit amet mollis.